The role of an alpha-amino group on H+ -dependent transepithelial transport of cephalosporins in Caco-2 cells.
The role of an alpha-amino group on interaction with the intestinal and renal peptide carriers (PEPT 1 and PEPT 2, respectively) has been the subject of much investigation. Studies have differed in their conclusions about the role of an alpha-amino group on carrier-mediated absorption. Most studies have used brush-border membrane vesicles or perfused intestinal segments. These techniques enable the determination of membrane uptake and luminal disappearance, respectively, but not transepithelial transport. Transepithelial transport should be more predictive of absorption because it includes basolateral efflux, which could be the rate-limiting process in drug absorption. The objective of this study was to evaluate the influence of an alpha-amino group on PEPT 1-mediated transepithelial transport in Caco-2 cells. The apical-to-basolateral permeability coefficients of cephalosporins with or without a free alpha-amino group were determined in the presence and absence of a pH gradient. Permeability coefficients obtained under these conditions were used to calculate a permeability ratio (i.e. P(app) (pH 6.0)/P(app) (pH 7.4)), which should indicate whether PEPT 1 is involved in transport. For cephalosporins with an alpha-amino group (cephalexin, cefaclor, cefadroxil, cephradine, cephaloglycin) the permeability ratios ranged between 1.77 and 2.77. In contrast, the permeability ratios for cephalosporins without an alpha-amino group were 1 (approx.; range = 0.74-1.26). These data suggest that the presence of an alpha-amino group on cephalosporins increases their PEPT 1-mediated transepithelial transport in Caco-2 monolayers.
Raeissi
S D
SD
Drug Metabolism and Pharmacokinetics, Rhone-Poulenc Rorer Central Research, Collegeville, PA 19426-0107, USA.
Li
J
J
Hidalgo
I J
IJ
D000588:Amines / Q000737:chemistry; D018938:Caco-2 Cells; D015820:Cadherins; D002352:Carrier Proteins / Q000378:metabolism; D002511:Cephalosporins / Q000737:chemistry* / Q000493:pharmacokinetics*; D004727:Endothelium / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000378:metabolism; D026901:Membrane Transport Proteins; D010539:Permeability / Q000187:drug effects; D017494:Proton Pumps / Q000187:drug effects*
D000588:Amines; C490584:CDH17 protein, human; D015820:Cadherins; D002352:Carrier Proteins; D002511:Cephalosporins; D026901:Membrane Transport Proteins; D017494:Proton Pumps; C067802:intestinal peptide-proton cotransporter